China NMPA Inspection - Tianjin Shengshi Yongye Technology Development Co., Ltd. - January 02, 2020

The National Medical Products Administration (NMPA) of China, a key regulatory body overseeing drug and cosmetic supervision, issued a public notification on January 2, 2020, regarding an unannounced inspection of Tianjin Shengshi Yongye Technology Development Co., Ltd. This notification, identified by index number JGXX-2020-10001, serves to inform stakeholders about the regulatory activity concerning the aforementioned company. The provided document is solely a formal announcement of the inspection's occurrence. It does not contain specific details regarding the actual dates of the inspection, any identified violations or issues, or any subsequent required corrective actions or outcomes. The NMPA operates under a framework that includes applications such as the China Drug Administration App and Cosmetics Supervision App, indicating its broad regulatory oversight in these sectors. Further information regarding the inspection's findings or any resulting compliance directives would typically be detailed in a separate report, which is not included in this notification.